Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-6 of 6 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

    Rochester, MN

  2. Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

    Rochester, MN

  3. Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/​Round Cell Liposarcoma

    Jacksonville, FL

  4. A Study to Evaluate the Safety and Effectiveness of Idecabtagene Vicleucel to Treat Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  5. Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells

    Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. Attitudes and Beliefs About Gene Transfer Therapy in Adults with Cocaine Use Disorder

    Rochester, MN

.

Mayo Clinic Footer